Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Boehringer’s nerandomilast shows promise in phase 3 pulmonary fibrosis study

The company said it will now be submitting a new drug application for the candidate in this indication

- PMLiVE

CSL Behring announces four-year results for haemophilia B gene therapy Hemgenix

The genetic bleeding disorder affects an estimated one per every 19,283 male births in the US

- PMLiVE

AbbVie announces FDA approval of antibiotic combination for intra-abdominal infections

Antimicrobial resistance has been declared by WHO as one of the top ten threats to global health

- PMLiVE

Eli Lilly shares two-year results for Omvoh in active Crohn’s disease patients

Inflammatory bowel disease affects almost one in every 100 people in the US

- PMLiVE

Inizio appoints Jim Sage as president of Inizio Engage

Sage previously served as North American regional president for Pfizer's internal medicine business

- PMLiVE

Roche announces positive late-stage results for Gazyva/Gazyvaro in lupus nephritis

The disease affects approximately 1.7 million people worldwide and primarily impacts women

EU flag

CHMP recommends Bavarian Nordic’s chikungunya vaccine for individuals aged from 12 years

Approximately 480,000 cases of the mosquito-borne viral disease were reported globally in 2024

- PMLiVE

Inizio appoints Remco op den Kelder as president of Inizio Advisory

Op den Kelder most recently served as chief executive office of Inizio Advisory’s Putnam

Patient talking to healthcare professional

Two Sides of the Same Coin: Patient Engagement vs Patient Involvement

Unpack the difference between patient engagement and patient involvement.

Cuttsy + Cuttsy

- PMLiVE

Hitting Every Beat—The Power of Education in Heart Failure

Heart failure is a common medical condition, with new treatment approaches being developed every day. By 2030, an estimated 8.5 million Americans will be living with heart failure. With more...

Medscape Education

- PMLiVE

Do Healthcare Providers Really Want to Go Back to In-person Meetings?

Healthcare professionals (HCPs) are increasingly seeking flexibility and convenience in their interactions with pharmaceutical and life sciences companies. This shift towards digital and blended approaches presents a valuable opportunity for...

Impetus Digital

- PMLiVE

Novo Nordisk’s haemophilia A therapy Mim8 shows promise in late-stage study

The inherited bleeding disorder accounts for up to 85% of the 1,125,000 global haemophilia cases

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links